SCHEMBL19481403

SCHEMBL19481403

CC[C@H]1CC[C@H](c2ccc(-c3cnc(-c4ccc(C[C@H](NC(=O)c5ccc(OC(F)(F)F)cc5)C(=O)O)cc4)nc3)cc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR132 Q9UNW8 3/20 0.46
▸ KLKB1 P03952 2/20 0.43
▸ EPHX2 P34913 2/20 0.42
▸ PPARG P37231 2/20 0.42
▸ PPARA Q07869 2/20 0.42
▸ FPR2 P25090 1/20 0.40
▸ CA2 P00918 1/20 0.39
▸ USP30 Q70CQ3 1/20 0.39
▸ CHRM2 P08172 1/20 0.39
▸ CHRM1 P11229 1/20 0.39
▸ ITGB1 P05556 2/20 0.38
▸ ITGA4 P13612 2/20 0.38
▸ ITGB7 P26010 1/20 0.38
▸ DGAT1 O75907 1/20 0.38
▸ PDK1 Q15118 1/20 0.38
▸ PDK2 Q15119 1/20 0.38
▸ PDK3 Q15120 1/20 0.38
▸ PDK4 Q16654 1/20 0.38
▸ ITGB3 P05106 1/20 0.37
▸ ITGA2B P08514 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17834663 0.92 GPR132 (0.47) GPR132KLKB1EPHX2PPARGPPARA
SCHEMBL17834644 0.90 KIFC1 (0.43) GPR132EPHX2PPARGPPARAFPR2
SCHEMBL17834635 0.90 ITGB1 (0.40) GPR132CA2ITGB1ITGA4DGAT1
SCHEMBL17834646 0.89 ITGB3 (0.44) GPR132KLKB1CA2ITGB1ITGA4
SCHEMBL22384492 0.89 ITGB3 (0.44) GPR132KLKB1CA2ITGB1ITGA4
SCHEMBL17834684 0.89 GPR132 (0.41) GPR132KLKB1CA2ITGB1ITGA4
SCHEMBL17834788 0.88 L3MBTL1 (0.40) GPR132CA2ITGB1ITGA4ITGB7
SCHEMBL17834669 0.88 DGAT1 (0.41) GPR132CA2ITGB1ITGA4DGAT1
SCHEMBL17834643 0.88 ITGB1 (0.40) GPR132CA2ITGB1ITGA4DGAT1
SCHEMBL17834638 0.88 ITGB1 (0.40) GPR132CA2ITGB1ITGA4DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10034886-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2018-07-31 — — US disclosed
US-10034886-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2018-07-31 — — US disclosed
US-9795613-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2017-10-24 — — US disclosed
US-9795613-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2017-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10034886-B2 GLP-1 receptor modulators GLP1R, GIPR, GCGR GPR132 228/4885KLKB1 2865/4885EPHX2 4326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback